These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 20566011)
1. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Childs MA; Wood CG; Spiess PE; Debiane LG; Hernandez M; Matin SF; Millikan RE; Siefker-Radtkie A; Scott SM; Pisters LL Can J Urol; 2010 Jun; 17(3):5184-9. PubMed ID: 20566011 [TBL] [Abstract][Full Text] [Related]
2. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? Sweeney P; Millikan R; Donat M; Wood CG; Radtke AS; Pettaway CA; Grossman HB; Dinney CP; Swanson DA; Pisters LL J Urol; 2003 Jun; 169(6):2113-7. PubMed ID: 12771730 [TBL] [Abstract][Full Text] [Related]
3. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma. Rao SR; Correa JJ; Sexton WJ; Pow-Sang JM; Dickinson SI; Lin HY; Spiess PE BJU Int; 2012 Dec; 110(11 Pt B):E475-80. PubMed ID: 22564727 [TBL] [Abstract][Full Text] [Related]
4. Combining hand assisted laparoscopic nephroureterectomy with cystoscopic circumferential excision of the distal ureter without primary closure of the bladder cuff--is it safe? Kurzer E; Leveillee RJ; Bird VG J Urol; 2006 Jan; 175(1):63-7; discussion 67-8. PubMed ID: 16406870 [TBL] [Abstract][Full Text] [Related]
5. Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes. Abe T; Shinohara N; Muranaka M; Sazawa A; Maruyama S; Osawa T; Harabayashi T; Kubota K; Matsuno Y; Shibata T; Toyada Y; Shinno Y; Minami K; Sakashita S; Kumagai A; Takada N; Togashi M; Sano H; Mori T; Nonomura K Eur J Surg Oncol; 2010 Nov; 36(11):1085-91. PubMed ID: 20832972 [TBL] [Abstract][Full Text] [Related]
6. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110 [TBL] [Abstract][Full Text] [Related]
7. Standardized and Simplified Retroperitoneal Lymph Node Dissection During Retroperitoneal Laparoscopic Radical Nephroureterectomy for Urothelial Carcinoma of the Upper Ureter or Renal Pelvis: En Bloc Resection Technique. Kanno T; Kobori G; Kubota M; Funada S; Haitani T; Okada T; Higashi Y; Moroi S; Yamada H Urology; 2018 Feb; 112():85-91. PubMed ID: 29158173 [TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148 [TBL] [Abstract][Full Text] [Related]
9. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147 [TBL] [Abstract][Full Text] [Related]
10. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience. Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694 [TBL] [Abstract][Full Text] [Related]
12. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy. Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244 [TBL] [Abstract][Full Text] [Related]
13. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. Roscigno M; Shariat SF; Margulis V; Karakiewicz P; Remzi M; Kikuchi E; Langner C; Lotan Y; Weizer A; Bensalah K; Raman JD; Bolenz C; Guo CC; Wood CG; Zigeuner R; Wheat J; Kabbani W; Koppie TM; Ng CK; Suardi N; Bertini R; Fernández MI; Mikami S; Isida M; Michel MS; Montorsi F J Urol; 2009 Jun; 181(6):2482-9. PubMed ID: 19371878 [TBL] [Abstract][Full Text] [Related]
14. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Lughezzani G; Jeldres C; Isbarn H; Shariat SF; Sun M; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI Urology; 2010 Jan; 75(1):118-24. PubMed ID: 19864000 [TBL] [Abstract][Full Text] [Related]
15. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. Colin P; Ouzzane A; Pignot G; Ravier E; Crouzet S; Ariane MM; Audouin M; Neuzillet Y; Albouy B; Hurel S; Saint F; Guillotreau J; Guy L; Bigot P; De La Taille A; Arroua F; Marchand C; Matte A; Fais PO; Rouprêt M; BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245 [TBL] [Abstract][Full Text] [Related]
19. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract. Komatsu H; Tanabe N; Kubodera S; Maezawa H; Ueno A J Urol; 1997 May; 157(5):1622-4. PubMed ID: 9112490 [TBL] [Abstract][Full Text] [Related]
20. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. Seitz C; Gupta A; Shariat SF; Matsumoto K; Kassouf W; Walton TJ; Fritsche HM; Otto W; Tritschler S; Bastian PJ; Carballido J; Ficarra V; Karakiewicz PI; Artibani W; Mazzoleni G; Novara G J Urol; 2010 Nov; 184(5):1895-900. PubMed ID: 20846680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]